Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Evonetix Granted Patent for DNA Data Storage and Retrieval Method
EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and […]
Researchers Investigate New Treatment for Diabetes to Combat Sight Loss
Researchers at the University of Aberdeen are investigating a new treatment for diabetes which they […]
Clearsense Acquires Plug-and-Play AI Analytics Firm
Clearsense, an AI-powered data analytics platform company that translates healthcare data into highly consumable insights, today announced […]
LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director
LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]
Pfizer and Biontech Expand Collaboration with U.S. to Provide 500 Million Additional Covid-19 Vaccine Doses at Not-for-profit Price for Donation to Poorest Countries
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced plans to expand their […]
Steven Penn Joins Care Angel as Chief Financial Officer/Chief Operations Officer
Care Angel, the leader in AI and voice-enabled nurse assistant technology, today announced that Steven Penn has joined […]
Novartis Acquires Arctos Medical, Expanding Optogenetics Portfolio to Bring Gene Therapies to Patients with Severe Vision Loss
Novartis today announced that it has acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene […]
Olympus Strengthens Surgical Portfolio with the Launch of POWERSEAL Advanced Bipolar Surgical Energy Devices
Olympus Corporation (Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced the launch of the first […]
Amphista Therapeutics Appoints New Chairman, Joshua T. Brumm
Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the […]
Naobios Manufactures FluGen Inc’s M2SR Influenza Vaccine Candidate for Upcoming Clinical Trials
Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more